[{"AccountsPayableCurrent_0_Q1_USD":9208000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-49157000.0,"DebtInstrumentConvertibleConversionPrice1_0_Q1_USD":0.04,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":4975000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1_Q1_USD":41.16,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":15408000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":412417.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":125121.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":25.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":5750958.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":15408000.0,"InterestExpenseDebt_1_Q1_USD":6400000.0,"ProceedsFromWarrantExercises_1_Q1_USD":0.0,"DebtInstrumentFaceAmount_0_Q1_USD":316250000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":6092000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":254000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":20.94,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":14.06,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":28.52,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":8701163.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-5222000.0,"DebtInstrumentUnamortizedDiscount_0_Q1_USD":122417000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q1_USD":0.05,"OtherAssetsNoncurrent_0_Q1_USD":1152000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":4157000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-28000.0,"InvestmentsFairValueDisclosure_0_Q1_USD":130552000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":15834000.0,"OtherNoncashIncomeExpense_1_Q1_USD":39000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":15465000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":10829000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":5614000.0,"OperatingLeaseLiability_0_Q1_USD":16443000.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":14190000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":1878000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":40859000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-9761000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":264731000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":130552000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":130683000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":216000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":85000.0,"AssetsFairValueDisclosure_0_Q1_USD":264731000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":10838000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":0.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":1261000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":7444000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":10529000.0,"ShortTermInvestments_0_Q1_USD":130552000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":3640000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":69352000.0,"InterestAndOtherIncome_1_Q1_USD":1100000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-1048000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-1422000.0,"LiabilitiesCurrent_0_Q1_USD":79145000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":412277000.0,"Liabilities_0_Q1_USD":285068000.0,"InventoryNet_0_Q1_USD":20225000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":2410000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":4587000.0,"IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_1_Q1_USD":-3952000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-33000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-49162000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.07,"Depreciation_1_Q1_USD":1591000.0,"CostsAndExpenses_1_Q1_USD":64281000.0,"CommonStockValue_0_Q1_USD":46000.0,"CommonStockSharesOutstanding_0_Q1_shares":46476185.0,"CommonStockSharesIssued_0_Q1_shares":46476185.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":134179000.0,"AssetsCurrent_0_Q1_USD":338437000.0,"Assets_0_Q1_USD":412277000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":9370466.0,"AdditionalPaidInCapital_0_Q1_USD":1072412000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-120000.0,"AccountsReceivableNetCurrent_0_Q1_USD":42941000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":33483000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_1_Q1_USD":50557000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-41822000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1240000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":12129000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":44000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":11684.0,"ShareBasedCompensation_1_Q1_USD":10529000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":36902000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":19173000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":15000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-43940000.0,"ConvertibleLongTermNotesPayable_0_Q1_USD":193833000.0,"CommonStockSharesAuthorized_0_Q1_shares":150000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommitmentsAndContingencies_0_Q1_USD":null,"AdjustmentForAmortization_1_Q1_USD":6585000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":64323000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":45792504.0,"StockholdersEquity_0_Q1_USD":127209000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-945129000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":57223000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":10540000.0,"NetIncomeLoss_1_Q1_USD":-49129000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":20341000.0,"Ticker":"AERI","CIK":"1337553","name":"AERIE PHARMACEUTICALS INC","OfficialName":"Aerie Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"408427417.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]